Research graph
References from Investigation of breast cancer molecular subtype in a multi-ethnic population using MRI. Local targets link to admitted publications; unresolved targets remain external evidence.
Breast MRI: State of the Art
10.1148/radiol.2019182947 · 2019 · External reference
Molecular portraits of human breast tumours
10.1038/35021093 · 2000 · External reference
Deconstructing the molecular portraits of breast cancer
10.1016/j.molonc.2010.11.003 · 2011 · External reference
Differences in clinical outcomes between luminal A and B type breast cancers according to the St. Gallen Consensus 2013
10.4048/jbc.2015.18.2.149 · 2015 · External reference
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors
10.1200/jco.2010.33.8889 · 2012 · External reference
Genetic heterogeneity and cancer drug resistance
10.1016/s1470-2045(11)70335-7 · 2012 · External reference
Magnetic Resonance Imaging Phenotypes of Breast Cancer Molecular Subtypes: A Systematic Review
10.1016/j.acra.2021.07.017 · 2022 · External reference
Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry
10.1007/s10549-010-1173-8 · 2011 · External reference
Unresolved reference
2013 · External reference
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update
10.5858/arpa.2018-0902-sa · 2018 · External reference
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update
10.5858/arpa.2019-0904-sa · 2020 · External reference
Clinical Notice for American Society of Clinical Oncology-College of American Pathologists Guideline Recommendations on ER/PgR and HER2 Testing in Breast Cancer
10.1200/jco.2011.35.2245 · 2011 · External reference
Correlation between imaging features and molecular subtypes of breast cancer in young women (≤30 years old)
10.1007/s11604-020-01001-8 · 2020 · External reference
MR imaging features of triple-negative breast cancers
10.1111/tbj.12182 · 2013 · External reference
Unresolved reference
External reference
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
10.1093/annonc/mdp062 · 2009 · External reference
10.1067/j.cpradiol.2018.08.003
10.1067/j.cpradiol.2018.08.003 · External reference
Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment
10.1038/s41598-021-92283-z · 2021 · External reference
Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma
10.1002/jmri.24934 · 2015 · External reference
Correlations between diffusion-weighted imaging and breast cancer biomarkers
10.1007/s00330-012-2403-8 · 2012 · External reference
Perfusion Parameters in Dynamic Contrast-enhanced MRI and Apparent Diffusion Coefficient Value in Diffusion-weighted MRI:: Association with Prognostic Factors in Breast Cancer
10.1016/j.acra.2015.12.011 · 2016 · External reference
Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer
10.1002/jmri.26697 · 2019 · External reference
Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution
10.3390/cancers15051385 · 2023 · External reference
Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging
2022 · External reference
Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer
2016 · External reference
The mammographic correlations of a new immunohistochemical classification of invasive breast cancer
10.1016/j.crad.2008.06.006 · 2008 · External reference
Breast cancer imaging features as a predictor of the hormonal receptor status, HER2neu expression and molecular subtype
2020 · External reference
Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner
10.1007/s10549-020-05592-8 · 2020 · External reference
Sensitivity and specificity of unilateral edema on T2w‐TSE sequences in MR‐Mammography considering 974 histologically verified lesions
10.1111/j.1524-4741.2010.00915.x · 2010 · External reference
